Clinical Trial Update: Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for EOF (epirubicin, oxaliplatin, and fluorouracil) in esophageal, gastroesophageal junction, or stomach cancers; trial completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• EOF (epirubicin, oxaliplatin, fluorouracil)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Esophageal Cancer, Gastric Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-04-19